JMP Securities Downgrades BioCryst Pharma (BCRX) to Market Perform
JMP Securities downgraded BioCryst Pharma (NASDAQ: BCRX) from Market ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
